HomeMRSN • NASDAQ
add
Mersana Therapeutics Inc
Previous close
$0.35
Day range
$0.32 - $0.36
Year range
$0.26 - $2.83
Market cap
40.59M USD
Avg Volume
2.68M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 2.75M | -70.21% |
Operating expense | 8.92M | -22.79% |
Net income | -24.12M | -24.95% |
Net profit margin | -875.93 | -319.45% |
Earnings per share | -0.19 | -18.75% |
EBITDA | -24.20M | -17.58% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 102.29M | -44.15% |
Total assets | 112.47M | -43.30% |
Total liabilities | 143.34M | -15.87% |
Total equity | -30.87M | — |
Shares outstanding | 124.63M | — |
Price to book | -1.40 | — |
Return on assets | -47.66% | — |
Return on capital | -950.15% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -24.12M | -24.95% |
Cash from operations | -29.33M | 10.20% |
Cash from investing | 27.00M | 137.22% |
Cash from financing | -3.14M | -153.82% |
Net change in cash | -5.46M | 94.50% |
Free cash flow | -18.69M | 13.99% |
About
Founded
2001
Website
Employees
102
